Preference for reversion to oxcarbazepine monotherapy: long-term outcome in patients with refractory partial seizures

被引：0
|
作者：
Gilliam, F
Qian, C
Riviere, ME
机构：
[1] Washington Univ, Dept Neurol, St Louis, MO USA
[2] Novartis Pharmaceut Corp, E Hanover, NJ USA
[3] Novartis Pharma AG, Basel, Switzerland
来源：
EPILEPSIA | 2004年 / 45卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：129 / 130
页数：2
相关论文
共 50 条
  • [21] Conversion to monotherapy - Clinical trials in patients with refractory partial seizures
    Beydoun, A
    Kutluay, E
    NEUROLOGY, 2003, 60 (11) : S13 - S25
  • [22] Lamotrigine monotherapy in patients with refractory partial-onset seizures
    Faught, E
    LAMOTRIGINE - A BRIGHTER FUTURE, 1996, (214): : 37 - 42
  • [23] Loss of effect (tolerance) during prolonged oxcarbazepine monotherapy for a subgroup of patients with partial seizures
    Schmidt, D
    Somogyi, M
    McCague, K
    NEUROLOGY, 2006, 66 (05) : A39 - A39
  • [24] Long-term treatment with responsive brain stimulation in adults with refractory partial seizures
    Bergey, Gregory K.
    Morrell, Martha J.
    Mizrahi, Eli M.
    Goldman, Alica
    King-Stephens, David
    Nair, Dileep
    Srinivasan, Shraddha
    Jobst, Barbara
    Gross, Robert E.
    Shields, Donald C.
    Barkley, Gregory
    Salanova, Vicenta
    Olejniczak, Piotr
    Cole, Andrew
    Cash, Sydney S.
    Noe, Katherine
    Wharen, Robert
    Worrell, Gregory
    Murro, Anthony M.
    Edwards, Jonathan
    Duchowny, Michael
    Spencer, David
    Smith, Michael
    Geller, Eric
    Gwinn, Ryder
    Skidmore, Christopher
    Eisenschenk, Stephan
    Berg, Michel
    Heck, Christianne
    Van Ness, Paul
    Fountain, Nathan
    Rutecki, Paul
    Massey, Andrew
    O'Donovan, Cormac
    Labar, Douglas
    Duckrow, Robert B.
    Hirsch, Lawrence J.
    Courtney, Tracy
    Sun, Felice T.
    Seale, Cairn G.
    NEUROLOGY, 2015, 84 (08) : 810 - 817
  • [25] Zonisamide in refractory partial-onset seizures: Long-term efficacy and safety
    Wroe, S.
    Yeates, A. B.
    EUROPEAN JOURNAL OF NEUROLOGY, 2007, 14 : 26 - 27
  • [26] Long-term outcome of refractory peptic ulcer patients
    Remacha, B
    Lanas, A
    GUT, 1997, 41 : A197 - A197
  • [27] LONG-TERM SAFETY AND EFFICACY OF GABAPENTIN (NEURONTIN) AS ADD-ON THERAPY IN PATIENTS WITH REFRACTORY PARTIAL SEIZURES
    ANHUT, H
    ASHMAN, PJ
    FEUERSTEIN, TJ
    QUEBEFEHLING, E
    SAUNDERS, M
    BARON, BA
    BAUER, G
    DEISENHAMMER, E
    KLINGLER, D
    MAMOLI, B
    GRAF, M
    DANTA, G
    VAJDA, F
    BUCHANAN, N
    SCHAPEL, GJ
    BLACK, A
    BAJADA, S
    DEBARSY, T
    LATERRE, C
    VANZANDIJCKE, M
    MCLACHLAN, RS
    PURVES, SJ
    LEE, MA
    BRUNI, J
    GAWEL, M
    HOLTLARSEN, B
    WERDELIN, L
    DALBY, MA
    IIVANAINEN, MV
    RIEKINNEN, PJ
    SIVENIUS, JMR
    LECLERCQ, E
    REMY, C
    SALLOU, C
    BILL, PLA
    PERSSON, LI
    SODERFELDT, B
    RICHENS, A
    JOURNAL OF EPILEPSY, 1995, 8 (01): : 44 - 50
  • [28] THE LONG-TERM EXPERIENCE OF MONOTHERAPY WITH OXCARBAZEPINE AND LEVETIRACETAM IN THE TERTIARY EPILEPSY CENTER
    Lim, J.
    Kang, B. S.
    Byun, J.
    Park, B. S.
    Shin, J. W.
    Kim, Y. S.
    Chu, K.
    Lee, S. K.
    EPILEPSIA, 2012, 53 : 54 - 55
  • [29] Long-term outcome of vagus nerve stimulation for refractory partial epilepsy
    Chavel, SM
    Westerveld, M
    Spencer, S
    EPILEPSY & BEHAVIOR, 2003, 4 (03) : 302 - 309
  • [30] MONOTHERAPY VERSUS POLYTHERAPY FOR LONG-TERM CONTROL OF SEIZURES
    SACHDEO, R
    CHOKROVERTY, S
    EPILEPSIA, 1986, 27 (05) : 646 - 646
12345